He Needs an Expensive Drug. A Copay Card Helped — Until It Didn’t.
Over the course of 2025, Jayant Mishra of Mission Viejo, California, progressively developed scaly, itchy…
He Needs an Expensive Drug. A Copay Card Helped — Until It Didn’t.
Over the course of 2025, Jayant Mishra of Mission Viejo, California, progressively developed scaly, itchy red patches on his skin. Then came the pain and swelling in the joints of his hands, making it difficult to do his work at a bank. His primary care doctor referred him to a rheumatologist, who diagnosed psoriatic arthritis….
To Avoid Care Disruptions, Know When the Clock Runs Out on Your Prior Authorization
A woman with multiple sclerosis wanted to be able to walk up the stairs at home without losing her balance. Her doctor prescribed medicine that helped, but then approval from her insurance plan for the drug expired. “Why do I need a prior authorization for something that I am already prior-authorized to take? If my…
How Elevance Health Is — and Isn’t — Using AI
Ratnakar Lavu, Elevance Health’s chief digital information officer, said the company is using AI to streamline approvals, claims processing and member support while keeping denials under human review. The post How Elevance Health Is — and Isn’t — Using AI appeared first on MedCity News.
FDA Voucher Leads to Speedy Approval of Boehringer Drug for First-Line Use in Lung Cancer
The label expansion for Boehringer Ingelheim’s Hernexeos was made under an FDA pilot program that accelerates regulatory review of products with national interest. The daily pill is now approved as a first-line treatment for HER2-positive non-small lung cancer, an indication with few treatment options. The post FDA Voucher Leads to Speedy Approval of Boehringer Drug…
Collective Health Collaborates with Google Cloud to Launch New AI-Powered System
Collective Health partnered with Google Cloud to launch an AI-powered system that helps members navigate benefits and streamlines plan administration for employers. The post Collective Health Collaborates with Google Cloud to Launch New AI-Powered System appeared first on MedCity News.
What the Health? From KFF Health News: What About the State of Health?
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A…
Where to Buy Laboratory Freeze Dryers for Sample Preservation
[Sponsored] Biological samples act as a foundation of modern scientific research and medicine, providing breakthroughs in diagnostics, therapeutic development and understanding of human biology. The post Where to Buy Laboratory Freeze Dryers for Sample Preservation appeared first on MedCity News.
Boehringer Boosts Pipeline, Adding Oral Small Molecules With Broad Immunology & Inflammation Potential
Boehringer Ingelheim receives rights to oral small molecules from Sitryx with potential applications in multiple autoimmune disorders. Depending on the progress of Boehringer’s research, Sitryx could receive more than $500 million. The post Boehringer Boosts Pipeline, Adding Oral Small Molecules With Broad Immunology & Inflammation Potential appeared first on MedCity News.
How Will the Loss of Enhanced Premium Tax Credits Affect Older Adults?
Marketplace enrollees between the ages of 50 and 64 are disproportionately affected by the expiration of the enhanced premium tax credits, not just because they make up a large number of Marketplace enrollees, but also because the cost of Marketplace premiums tend to rise with age. Older ACA enrollees with annual incomes just above 400%…
Compliance: Why Your Vendor’s Vendor is a Growth Risk
The core challenge for leadership is no longer merely managing direct vendors; it’s the cascading risk of the “nth-party” supplier. The post Compliance: Why Your Vendor’s Vendor is a Growth Risk appeared first on MedCity News.
